GPT and breast cancer: These trials also revealed an increased risk of grade 3/4 elevations of alanine aminotransferase (ALT), with palbociclib – but were limited in size and breast cancer disease severity in evaluating less common AEs such as acute liver injury (ALI) [1–3].